Lab-on-a-chip technologies deliver diagnostic tools for infection and disease
Published: 3 December 2013
Fifteen years of research in advanced Lab-on-a-Chip technologies at the University of Glasgow has led to three spin-out companies: Mode-Dx, Clyde Biosciences and SAW-Dx.
Fifteen years of research in advanced Lab-on-a-Chip technologies at the University of Glasgow has led to three spin-out companies: Mode-Dx, Clyde Biosciences and SAW-Dx.
Since 2008 these companies have developed a range of products and services for the diagnostic screening of chronic diseases, for the detection of acute infections and for improving the drug discovery process.
The three companies have secured a total of £2.3M in venture funding and secured key strategic collaborations with stakeholders including industry partners and the NHS.
ModeDx, Left, measure® BOWEL HEALTH is a hand-held biosensor for measuring faecal occult blood; Right, schematic showing an exploded view of the faecal sampling interface to the biosensor device.
Clyde Biosciences (left) the CellOPTIQ instrument; (right) proprietary image-analysis software enabling real-time, multiplexed electrophysiological measurements.
Related research
First published: 3 December 2013